Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department
qSOFAST
Usefulness of Routine qSOFA Calculation at Triage to Fasten Antimicrobial Administration in Patients With Bacterial Infection in the Emergency Department: a Quasi-experimental Study
1 other identifier
interventional
780
1 country
1
Brief Summary
The delayed administration of an adequate antimicrobial therapy is a strong predictor of impaired outcome in patients with bacterial sepsis. Therefore, the current Surviving Sepsis Campaign guidelines (2016) recommend that administration of intravenous antimicrobials be initiated within one hour following the recognition of sepsis or septic shock. The quick Sepsis-related Organ Failure Assessment (qSOFA) score is a new bedside tool which has been recently proposed by the Third International Sepsis Consensus Definitions Task Force (Sepsis-3) to identify patients with suspected infection who are at greater risk for a poor outcome outside the Intensive Care Unit (ICU). It uses three criteria, assigning one point for low systolic blood pressure (SBP ≤100 mmHg), high respiratory rate (≥22 breaths per min) and altered mentation (Glasgow coma scale \<15). The score ranges from 0 to 3 points. A qSOFA value ≥2 points is associated with a greater risk of death or prolonged ICU stay, these outcomes being more common in infected patients who may be septic than in those with uncomplicated infection. The definite goal of qSOFA is to hasten the management and thus improve the outcome of patients at risk of sepsis or septic shock. Many patients admitted to the hospital for bacterial sepsis or septic shock are initially managed in the Emergency Department (ED). This study aims at investigating whether the routine calculation of qSOFA at patient triage may hasten the initiation of antimicrobial therapy in patients admitted to the ED with suspected or proven bacterial infection, especially in those with subsequent criteria for sepsis or septic shock (Sepsis-3 definition).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2017
CompletedFirst Posted
Study publicly available on registry
October 3, 2017
CompletedStudy Start
First participant enrolled
October 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2018
CompletedAugust 1, 2018
July 1, 2018
8 months
September 25, 2017
July 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients who receive a first dose of antimicrobial agent
Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) who receive a first dose of antimicrobial agent within one hour following triage in the emergency department.
one hour
Secondary Outcomes (8)
Proportion of patients who receive a first dose of adequate antimicrobial agent
one hour
Proportion of patients who receive a first dose of antimicrobial agent
three hours
Proportion of patients who receive a first dose of adequate antimicrobial agent
three hours
Proportion of patients with a decrease in SOFA score value ≥ 1 point
two days
Proportion of patients requiring an admission to the Intensive Care Unit
two days
- +3 more secondary outcomes
Study Arms (2)
systematic calculation of qSOFA
EXPERIMENTALUsual procedure for patient triage AND systematic calculation of qSOFA at Emergency Department triage in patients admitted with a suspected or proven bacterial infection.
no systematic calculation of qSOFA
NO INTERVENTIONUsual procedures for patient triage at Emergency Department admission and management of suspected or proven bacterial infection. No systematic calculation of qSOFA.
Interventions
calculation of qSOFA for each patient
Eligibility Criteria
You may qualify if:
- Suspected or proven bacterial infection at emergency department triage
You may not qualify if:
- Imminent death
- Pregnancy
- Breast-feeding
- For patients managed by a medicalized pre-hospital emergency team before ED admission : administration of a first dose of antimicrobial agent before ED admission
- Lack of coverage by the public health insurance system
- Patient's refusal for study enrollment
- Lack of confirmed bacterial infection (i.e., documented either clinically, microbiologically or by imaging procedures) in patients with a suspected bacterial infection at emergency departement triage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Regional Hospital center of Orleans
Orléans, 45067, France
Related Publications (2)
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
PMID: 26903338BACKGROUNDPetit J, Passerieux J, Maitre O, Guerin C, Rozelle C, Cordeau O, Cassonnet A, Malet A, Boulain T, Barbier F; qSOFAST study group. Impact of a qSOFA-based triage procedure on antibiotic timing in ED patients with sepsis: A prospective interventional study. Am J Emerg Med. 2020 Mar;38(3):477-484. doi: 10.1016/j.ajem.2019.05.022. Epub 2019 May 10.
PMID: 31103379DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julien PASSERIEUX, MD
Regional Hospital Center of Orleans
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2017
First Posted
October 3, 2017
Study Start
October 12, 2017
Primary Completion
June 10, 2018
Study Completion
June 10, 2018
Last Updated
August 1, 2018
Record last verified: 2018-07